tiprankstipranks
Trending News
More News >
CytomX Therapeutics Inc (CTMX)
NASDAQ:CTMX
US Market

CytomX Therapeutics (CTMX) Income Statement

Compare
646 Followers

CytomX Therapeutics Income Statement

Last quarter (Q4 2024), CytomX Therapeutics's total revenue was $38.09M, an increase of 43.17% from the same quarter last year. In Q4, CytomX Therapeutics's net income was $18.88M. See CytomX Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 138.10M$ 101.21M$ 53.16M$ 69.57M$ 100.36M
Gross Profit
$ 138.10M$ 101.21M$ 47.31M$ 63.73M$ 100.36M
Operating Expenses
$ 113.11M$ 107.70M$ 154.50M$ 153.35M$ 148.97M
Depreciation and Amortization
$ 0.00$ 2.17M$ 5.86M$ 5.84M$ 5.46M
EBITDA
$ 25.00M$ -4.31M$ -98.89M$ -113.34M$ -77.97M
Operating Income
$ 25.00M$ -6.48M$ -101.33M$ -83.78M$ -48.60M
Other Income/Expenses
$ 7.10M$ 9.81M$ 2.02M$ 172.00K$ 1.81M
Pretax Income
$ 32.09M$ 3.32M$ -99.32M$ -83.61M$ -46.80M
Net Income
$ 31.87M$ -569.00K$ -97.30M$ -80.65M$ -32.88M
Per Share Metrics
Basic EPS
$ 0.38$ -0.01$ -1.48$ -1.26$ -0.71
Diluted EPS
$ 0.38$ -0.01$ -1.48$ -1.26$ -0.71
Weighted Average Shares Outstanding
84.44M 73.81M 65.74M 64.15M 46.15M
Weighted Average Shares Outstanding (Diluted)
84.75M 73.81M 65.74M 64.15M 46.15M
Currency in USD

CytomX Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis